⌘ Services
mob-logo
Contact Us 800.227.0627
Contact Quote Order Login / Register

Custom Peptide Dendrimer Synthesis

Design and synthesis of generation-based peptide dendrimers, peptide dendrons, and multifunctional multivalent constructs for targeting, vaccine research, molecular imaging, delivery systems, antimicrobial studies and nanomedicine.

Lysine-Based Dendrimers Controlled Valency Dendrons Multifunctional Conjugates HPLC/UPLC & MS Characterization
Request a Quote Explore Design Options
Overview Selection Guide Architecture Design Capabilities Applications Related Services Quality Contact
Advanced Multivalent Peptide Platform

Dendrimer Peptides for Advanced Multivalent Design

Peptide dendrimers are sequence-defined, generation-based macromolecular architectures that display multiple functional ligands from a common branching scaffold. By controlling branch generation, terminal valency, linker composition, spatial presentation, and surface functionality, these constructs support multivalent molecular recognition, targeted delivery, molecular imaging, vaccine research, antimicrobial studies, and multifunctional conjugate development.

Bio-Synthesis designs and manufactures custom peptide dendrimers, peptide dendrons, and hybrid dendritic constructs using lysine and other amino acid-based branching units. The biological objective, scaffold chemistry, generation, terminal valency, ligand accessibility, linker strategy, purification route, and analytical characterization plan are engineered together so the final construct is practical to manufacture and aligned with its intended application.

Peptide dendrimer structural hierarchy A clean schematic of a generation-based peptide dendrimer with a core scaffold, three branching generations, eight terminal groups, and a separate legend of representative terminal functions. Generation-Based Peptide Dendrimer Architecture Defined branching, terminal valency, and surface functionality 1 2 3 4 5 6 7 8 CORE Generation 3 Generation 2 Generation 1 Representative Terminal Functions 1 Targeting ligand 2 Imaging label 3 Drug or payload 4 PEG or lipid 5 Oligonucleotide 6 Click handle 7 Chelator 8 Protein or ligand • Controlled terminal valency • Defined branch spacing

Representative peptide dendrimer hierarchy. The scaffold, branching generation, terminal valency, linker spacing, and terminal functions can be customized for the intended biological and analytical objective.

Generation-Based Architecture

Defined branching cycles with increasing terminal-group density.

Controlled Terminal Valency

Match the number of displayed ligands to the biological objective.

Multifunctional Molecular Engineering

Combine targeting, detection, delivery, or payload elements.

Project-Specific QC

Purification and analytical methods selected for molecular complexity.

Why Choose Dendrimer Peptides?

When Simple Branching Is Not Enough

Dendrimer peptides are most useful when a project requires high ligand density, controlled multivalency or several functions within one construct.

A

Increase Avidity

Present multiple copies of a binding ligand to promote cooperative target engagement when the receptor geometry and spacing are favorable.

F

Expand Functional Density

Create multiple terminal groups for peptide display, labeling, payload attachment or orthogonal conjugation strategies.

M

Integrate Multiple Functions

Combine targeting, imaging, therapeutic or delivery components within a single, defined molecular architecture.

Important design principle: all peptide dendrimers are multivalent architectures, but not every multivalent or branched peptide is a dendrimer. Dendrimers are distinguished by repeated, generation-based branching rather than a single branch point.

Key Design Principles

Generation

The number of iterative branching cycles built outward from the focal core.

Terminal Valency

The number of functional end groups available for ligand display or conjugation.

Ligand Density

The local concentration and spatial distribution of functional groups at the dendrimer surface.

Avidity

The combined strength of multiple interactions; it is distinct from the intrinsic affinity of one ligand.

Steric Accessibility

The ability of displayed ligands to reach their targets without shielding or crowding.

Charge & Solubility

Net charge, hydrophobic clustering, linker composition, molecular size, and hydrodynamic behavior can strongly influence solubility, aggregation, formulation, and biological handling.

Multivalent Peptide Selection Guide

Select the Architecture That Matches the Project

Use the tabs to compare structural architecture with functional design. Branched, MAP and dendrimer describe how a construct is built; multiepitope and bispecific describe what it is designed to do.

Choose Branched Peptides for Simple Multivalency

The broadest structural category: any peptide containing one or more branch points. Best when the construct needs a limited number of arms without a full generation-based dendritic scaffold.

2–4 arms Simple conjugation Receptor clustering
Classification

Structural umbrella

Branching

One or several branch points

Relative Molecular Complexity

Low to moderate

Representative Applications

Compact multivalent display

Choose MAP Peptides for Antigen Presentation

Multiple Antigen Peptide systems use a lysine-based branched core to present several copies of one or more antigenic peptide sequences, commonly for immunization and antibody-generation research.

Antigen display 4- or 8-arm formats Immunology
Classification

Specific branched architecture

Primary Purpose

Antigen presentation

Typical Core

Lysine matrix

Representative Applications

Antibody and vaccine research

Choose Dendrimer Peptides for High-Density, Multifunctional Design

Repeated branching generations create many terminal groups and support high-valency display or several distinct functions within one construct.

Generation-based High valency Multifunctional
Classification

Advanced dendritic architecture

Branching

Recursive generations

Relative Molecular Complexity

Moderate to high

Representative Applications

Targeting, delivery and imaging

Choose Multiepitope Peptides for Broader Immune Recognition

Multiepitope is a functional classification. Several distinct antigenic regions are combined in one construct, which may be linear, branched, MAP-based or dendrimeric.

Multiple epitopes Vaccine research Immune profiling
Classification

Functional design

Structure

Linear or branched

Sequence Content

Different antigenic regions

Representative Applications

Multi-antigen immune studies

Choose Bispecific Peptides for Dual-Target Engagement

Bispecific designs contain two different binding domains intended to engage two targets, receptors or cell types. They may be linear, branched or incorporated into a dendritic scaffold.

Two targets Dual binding Cell engagement
Classification

Functional design

Valency

Usually two specific domains

Structure

Linear or branched

Representative Applications

Dual-receptor targeting

Dendrimer Engineering Guide

Dendrimer Scaffold & Architecture Selection Guide

A dendrimer project involves several separate design decisions. First select the chemical scaffold, then define the molecular architecture, add the required functional components, and establish a manufacturing and characterization strategy. Bio-Synthesis can evaluate these layers together rather than treating them as isolated modifications.

1. Define Biological Objective
2. Select Scaffold
3. Choose Generation
4. Set Terminal Valency
5. Engineer Linkers
6. Add Functional Components
7. Plan Purification
8. Define Characterization
1

Select a Dendrimer Scaffold

The scaffold defines the core chemistry, branching behavior, payload capacity and compatibility with peptide synthesis or post-synthesis conjugation.

Lys core

Lysine Scaffold

Fully peptide-based branching compatible with SPPS, biodegradable designs and sequence-defined peptide dendrimers.

Best fit: peptide-rich constructs
PAMAM

PAMAM–Peptide Conjugate Concepts

Polymeric PAMAM scaffolds may be evaluated for projects requiring peptide functionalization, multivalent display, or payload attachment.

Project-specific feasibility review
PEGCargoLigand

PEG-Based Hybrid Scaffold

Hydrophilic spacing can improve solubility, reduce steric crowding and increase accessibility of terminal ligands.

Best fit: spacing and solubility
HybridLys + PEG/PAMAM

Hybrid Molecular Scaffold

Combines peptide, polymer or spacer elements to balance biodegradability, loading, accessibility and physicochemical behavior.

Best fit: multifunctional systems
2

Define the Molecular Architecture

Architecture describes how peptide domains are organized and what biological function the construct is intended to perform.

Y

Branched Peptide

One or several branch points for compact multivalent presentation.

Moderate valency
✳

MAP Peptide

Lysine-based multiple antigen display for immunology and antibody programs.

Antigen presentation
❉

Dendrimer Peptide

Generation-based recursive branching for high-density, multifunctional display.

High valency
●—●—●

Multiepitope Peptide

Several distinct epitopes arranged within one immune-focused construct.

Immune engineering
A⇄B

Bispecific Peptide

Two recognition domains designed to engage different targets or functions.

Dual targeting
3

Add Functional Components

Functionalization can be introduced during synthesis or through orthogonal post-synthesis conjugation, depending on the architecture and payload.

PEG Drug Payload Protein Oligonucleotide Fluorophore Lipid Click Handle Chelator Cleavable Linker Stable Isotope
4

Plan Manufacturing & Characterization

Purification and analytical methods must be selected for the final molecular construct, not for an unconjugated peptide alone.

Synthesis Strategy

  • Direct, convergent or modular assembly
  • Orthogonal protection and conjugation planning
  • Sequence- and generation-specific feasibility review

Purification

  • Preparative RP-HPLC
  • SEC or ion-exchange when appropriate
  • Project-specific desalting and formulation

Analytical Characterization

  • LC-MS or MALDI-TOF
  • Analytical HPLC/UPLC
  • Additional identity or content testing as applicable
Interactive Dendrimer Peptide Design Guide

Engineering Workflow for Peptide Dendrimers

Select each design dimension to review practical considerations affecting synthesis feasibility, biological performance and analytical characterization.

Start With the Lowest Valency That Can Test the Hypothesis

Increasing valency can improve avidity, but it also raises molecular weight, hydrophobicity, aggregation risk and purification difficulty.

2–4: compact 8: enhanced display 16+: advanced feasibility review
Define

Number of active terminal groups

Evaluate

Target spacing and receptor density

Watch

Solubility and steric crowding

Plan

Comparative lower-valency control

Select a Branching Scaffold Compatible With the Sequence

Lysine is commonly used, while Orn, Dab, Dap and custom multifunctional cores can adjust spacing and architecture.

Lys Orn Dab Dap Custom core
Core Choice

Controls branch spacing

Generation

Controls terminal-group count

Synthesis Route

Direct, convergent or modular

Constraint

Sequence-dependent feasibility

Use Linkers to Reduce Crowding and Preserve Function

Spacer length and flexibility should reflect ligand size, target accessibility and whether cargo release is required.

Ahx β-Ala PEG/TEG Gly/Ser Cleavable linker
Flexible

Improves reach and accessibility

Hydrophilic

Can improve aqueous handling

Cleavable

For triggered cargo release

Watch

Excessive flexibility or heterogeneity

Separate Functional Roles Where Possible

Define which branches carry targeting ligands, imaging labels, therapeutic sequences or conjugation handles and whether each component must be site-specific.

Targeting peptide Antigen Fluorophore Drug Lipid Oligo
Identity

Same or mixed terminal ligands

Placement

Peripheral or focal-point attachment

Orthogonality

Protecting-group and click strategy

Function

Confirm each component remains accessible

Design the Analytical Plan Before Synthesis

Large or highly branched peptides may require complementary purification and characterization methods because conventional RP-HPLC and electrospray MS do not perform equally well for every construct.

RP-HPLC SEC Ion exchange LC-MS MALDI-TOF AAA
Purity

Method and threshold by intended use

Identity

MS method selected by mass and charge

Content

Peptide content or amino acid analysis

Handling

Solubility, counterion and storage

Architecture Comparison

Branched, MAP, Dendrimer, Multiepitope and Bispecific Peptides

Feature Branched Peptides MAP Peptides Dendrimer Peptides Multiepitope Peptides Bispecific Peptides
Primary classification Structure Structure Structure Function Function
Defining feature One or more branch points Lysine-based antigen matrix Repeated generation-based branching Several distinct epitopes Two different binding specificities
Typical architecture Simple branched Commonly 4- or 8-arm Multigeneration dendritic scaffold Linear, branched, MAP or dendrimer Linear, branched or dendritic
Primary purpose Compact multivalent display Antigen presentation High-density or multifunctional display Broaden immune recognition Engage two biological targets
Relative complexity Low–moderate Moderate Moderate–high Sequence-dependent Sequence- and format-dependent
Typical applications Binding, clustering, conjugation Immunization, antibody research Targeting, imaging, delivery, nanomedicine Vaccine and immunology research Dual-targeting and cell engagement
Engineering Capabilities

Research Through Scale-Up Peptide Dendrimer Manufacturing

Each construct is reviewed for synthetic feasibility, protecting-group strategy, purification behavior, analytical suitability and scale.

Architecture or Feature Custom Support Project Considerations
Lysine and amino-acid dendrimers Generation, branch spacing and terminal density
Mixed or asymmetric peptide display Orthogonal protection and site-specific assembly
PEG, lipid or polymer integration Solubility, hydrophobicity and conjugation sequence
Fluorophore and imaging conjugates Dye loading, spectral requirements and labeling site
Peptide–drug or small-molecule conjugates Linker stability, release mechanism and payload compatibility
Peptide–oligonucleotide constructs Charge balance, conjugation chemistry and purification
Cleavable and bioorthogonal linkers Trigger conditions and orthogonal reaction handles
Research-to-larger-scale manufacturing Scale-up follows feasibility and process evaluation

Custom support indicates that the chemistry can be evaluated; it is not a guarantee that every sequence, generation, payload or scale will be feasible.

Analytical Characterization Strategy
QC

Characterization Selected for the Complete Dendrimer Construct

No single method is ideal for every peptide dendrimer. The analytical package is selected according to architecture, molecular mass, charge state, hydrophobicity, aggregation tendency, and the intended use of the material.

Technique Typical Purpose Project Considerations
RP-HPLC Purity assessment and preparative method development Retention and recovery may be affected by hydrophobic clustering and high charge density.
UPLC Higher-resolution separation of complex product and impurity profiles Useful when closely related truncation or incomplete-branching products must be resolved.
LC-MS / ESI-MS Molecular identity confirmation Ionization and charge-state distribution depend on size, composition, and terminal groups.
MALDI-TOF Mass analysis of larger or highly branched constructs Can complement ESI-based methods when ionization behavior is challenging.
SEC Assessment of size distribution, oligomerization, or aggregate-related species Most useful when an appropriate method and molecular-size range are available.
Amino Acid Analysis Peptide content or composition support when appropriate Applied selectively because some nonstandard residues or conjugates require alternative approaches.
Integrated Molecular Engineering

Integrated Molecular Engineering Platform

Bio-Synthesis can connect peptide architecture, oligonucleotide chemistry, bioconjugation, labeling and analytical characterization within one coordinated project. This integrated approach is especially valuable for multifunctional constructs that cross conventional service categories.

Peptide Engineering

Architecture & Sequence

Branched, MAP, dendrimer, cyclic, stapled, multiepitope and bispecific formats.

Bioconjugation

Functional Integration

Peptide–oligo, peptide–drug, peptide–protein, PEG, lipid and imaging conjugates.

Analytical Support

Purification & Characterization

Project-specific purification, HPLC/UPLC, mass spectrometry and documentation.

Applications

Where Dendrimer Peptides Add Value

Multivalent Targeting

Display repeated ligands to investigate avidity, receptor clustering and cell-surface recognition.

Vaccine Research

Present repeated or mixed antigenic sequences on a defined peptide-based scaffold.

Molecular Imaging

Combine targeting sequences with fluorescent or affinity labels for detection studies.

Drug & Cargo Delivery

Attach therapeutic sequences, small molecules, lipids, polymers or nucleic-acid cargo.

Antimicrobial Research

Explore topology, charge density and multivalent membrane interactions.

Gene Delivery Research

Evaluate cationic or ligand-functionalized dendritic constructs for nucleic-acid association.

Protein Mimicry

Organize functional residues in three-dimensional arrangements inspired by protein surfaces.

Diagnostic Probe Development

Combine recognition ligands, signal-generating labels, and defined spacers in multivalent detection constructs.

Representative Dendrimer Design Concepts

Representative Application-Specific Dendrimer Designs

The following non-confidential examples illustrate the types of design problems that can be evaluated. Final feasibility depends on sequence, payload, valency, purity and scale.

Targeting

High-Valency Receptor-Binding Dendrimer

Repeated targeting peptides with hydrophilic spacers to preserve accessibility and evaluate avidity.

Imaging

Targeted Molecular Imaging Dendrimer

Targeting modules, controlled fluorophore placement, and spacing designed to preserve recognition and signal performance.

Delivery

Peptide–Oligonucleotide Dendrimer

Multivalent peptide display combined with an oligonucleotide through a planned, site-specific conjugation strategy.

Vaccines

Multiepitope Antigen Dendrimer

Several antigenic sequences organized on a defined scaffold for immunogenicity and recognition studies.

Payload

Cleavable Payload Dendrimer

Targeting and cargo-bearing elements separated by a project-specific releasable linker.

Responsive Design

Stimuli-Responsive Dendrimer

Environment-sensitive or cleavable components incorporated for controlled activation, release, or signal generation.

Typical Project Specifications

Customizable Design and Manufacturing Options

Design Element Available Options Key Considerations
Architecture Dendron, symmetric dendrimer, asymmetric or modular construct Functional symmetry, synthesis route and purification
Branching units Lys, Orn, Dab, Dap or custom scaffold Branch spacing and protecting-group strategy
Generation and terminal valency Project-specific; compact to higher-valency designs Molecular weight, solubility, crowding and analytical feasibility
Terminal groups Identical or mixed peptide ligands and functional handles Site specificity and orthogonal chemistry
Conjugation Fluorophores, biotin, PEG, lipids, small molecules or oligonucleotides Payload stability and conjugation sequence
Purification RP-HPLC, SEC, ion exchange or combined methods Selected according to charge, size and hydrophobicity
Characterization Analytical HPLC/UPLC, LC-MS, MALDI-TOF and optional content testing Method suitability depends on construct complexity
Scale Research through larger custom quantities after feasibility review Yield generally decreases as valency and complexity increase
Before You Request a Quote

Dendrimer Peptide Design Checklist

Sequence of Every Peptide Domain

Include termini, stereochemistry and nonstandard residues.

Required Valency

State the number of copies of each functional ligand.

Linkers and Spacers

Define flexible, hydrophilic or cleavable linker requirements.

Purity and QC

Specify the intended application and minimum documentation.

Desired Architecture

Specify dendron or dendrimer, symmetry and tentative generation.

Branching Scaffold

Provide a preferred core or request design assistance.

Labels and Cargo

List fluorophores, drugs, lipids, PEG, oligos or handles.

Quantity and Formulation

Include scale, counterion, aliquoting and storage needs.

Frequently Ordered Together

Supporting Services for Complex Dendrimer Projects

PEGylated Peptides

Hydrophilic spacing, solubility support and conjugation options.
↗

Fluorescent Labeling

Terminal, internal or site-specific fluorescent peptide labeling.
↗

Stable Isotope Labeling

Heavy-labeled peptides for quantitative mass spectrometry workflows.
↗

Preparative HPLC

Purification strategies selected for charge, size and hydrophobicity.
↗

LC-MS Characterization

Analytical review and identity assessment for complex constructs.
↗

Cyclic Peptide Components

Conformationally constrained peptide domains for integrated designs.
↗
Pre-quote design review available: Bio-Synthesis can evaluate scaffold chemistry, branching generation, terminal valency, ligand spacing, linker strategy, conjugation chemistry, solubility, purification and analytical characterization before quotation.
Design Consultation & Quote

Need help designing a peptide dendrimer construct?

Provide the peptide sequence or functional ligand, preferred scaffold or architecture, desired generation or terminal valency, linker and spacer strategy, functional payloads or labels, target application, quantity, purity, formulation, analytical expectations and project timeline. Bio-Synthesis can review structural design, synthetic accessibility, purification strategy, analytical characterization and the most appropriate manufacturing approach.
Request a Quote Speak to a Scientist

Need help before quoting?

Email: info@biosyn.com
Phone: 800-227-0627 (US/CAN)
Phone: +001-972-420-8505 (INT)

What to Send

  • Peptide sequence or functional ligand
  • Preferred scaffold or architecture
  • Desired generation or terminal valency
  • Linkers and spacers
  • Functional payloads, labels or conjugation chemistry
  • Target application
  • Quantity, purity and formulation
  • Analytical expectations and project timeline

What We Review

Our scientists review scaffold selection, branch architecture, ligand density, steric accessibility, linker design, synthesis feasibility, purification strategy, analytical characterization and scale-up considerations to support a manufacturable dendrimer construct.

Quality Systems

Quality Systems & Manufacturing Support

QMS

ISO-Supported Peptide Manufacturing

Custom dendrimer peptides, multivalent constructs, modified peptides and peptide conjugates with controlled synthesis, purification, analytical QC, documentation and project-specific packaging.

ISO 9001:2015 Quality management system
ISO 13485:2016 Medical-device quality framework
ISO 14001 Environmental management system
Analytical QC HPLC/UPLC, MS where compatible, purity assessment and COA

Peptide Dendrimer Synthesis FAQ

FAQ

How are dendrimer peptides different from branched peptides?
Branched peptides may contain only one or a few branch points. Dendrimer peptides use repeated, generation-based branching to create a more highly organized architecture with multiple terminal groups.
Are MAP peptides a type of peptide dendrimer?
MAP systems are dendritic, lysine-based antigen matrices and are closely related to peptide dendrimers. For website organization, it is useful to retain MAP as a separate application-focused category because customers recognize it primarily for antigen presentation.
Can a dendrimer display different peptide sequences?
Yes. Mixed or asymmetric designs may be possible, but they require a carefully planned synthesis and protecting-group strategy.
What valency should I choose?
Begin with the lowest valency likely to test the biological hypothesis. Higher valency may increase avidity but can also increase crowding, aggregation and manufacturing difficulty.
Can dendrimer peptides include fluorophores or drugs?
Yes. Fluorophores, biotin, small molecules, lipids, PEG and other payloads can be reviewed for site-specific incorporation or post-synthesis conjugation.
Which purification method is best?
The optimal method depends on size, charge, hydrophobicity and heterogeneity. RP-HPLC may be combined with SEC or ion-exchange methods for complex constructs.
Can you synthesize high-generation dendrimers?
Higher-generation designs require feasibility review because steric crowding, incomplete coupling, purification and mass characterization become progressively more challenging.
What information is needed for a quotation?
Provide all sequences, a structural sketch, desired valency, branch core, linkers, modifications, quantity, purity and analytical requirements.
Why choose Bio-Synthesis for a dendrimer peptide project?
Bio-Synthesis can coordinate peptide architecture, specialized modifications, oligonucleotide and small-molecule conjugation, purification and analytical characterization within one custom project. This is useful when the final construct crosses multiple chemistry platforms.
Can Bio-Synthesis manufacture dendrimer peptides for preclinical and scale-up studies?
Yes. Bio-Synthesis supports custom dendrimer peptide projects from early-stage research through preclinical development and larger custom manufacturing quantities. Each project is reviewed for scaffold selection, molecular architecture, conjugation strategy, synthesis scale, purification and analytical characterization. Available quality-control methods may include HPLC or UPLC, LC-MS, MALDI-TOF and other project-specific testing, depending on the construct.
More FAQsAll FAQs
Scientific Background & Recommended Reading

Recommended Reading

Selected references covering peptide dendrimers, multivalent peptide engineering, dendritic architectures and biomedical applications.

  1. Tam JP. Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system. Proceedings of the National Academy of Sciences. 1988.
  2. Sadler K, Tam JP. Peptide dendrimers: applications and synthesis. Reviews in Molecular Biotechnology. 2002.
  3. Cloninger MJ. Biological applications of dendrimers. Current Opinion in Chemical Biology. 2002.
  4. Darbre T, Reymond JL. Peptide dendrimers as artificial enzymes, receptors and drug-delivery agents. Accounts of Chemical Research. 2006.
  5. Heegaard PMH, Boas U, Sorensen NS. Dendrimers for vaccine and immunostimulatory uses: a review. Bioconjugate Chemistry. 2010.
  6. Xie F, et al. Self-assembling peptide dendrimers for biomedical and theranostic applications. Advanced Drug Delivery Reviews. 2022.

Note: These references provide scientific background on dendrimer peptide chemistry and applications. Each custom construct should be evaluated individually for scaffold selection, molecular architecture, valency, linker design, synthesis feasibility, purification and analytical characterization.

Why Choose Bio-Synthesis

Trusted by biotech leaders worldwide for over 45 years of delivering high-quality, fast, and scalable synthetic biology solutions.

Greetings, Researchers,

Please be advised that any information, guidelines, write-ups, and oral/video/graphic content on our website are intended solely as general guidelines.
It is the researcher's sole responsibility to conduct thorough research on the design of products intended for their experiments before submitting
their designs to Biosynthesis for production feasibility review.
Thank you for your understanding.

Quick Links